GRID2 Gene Spinocerebellar Ataxia Type 18 Autosomal Recessive NGS Genetic DNA Test
Introduction
The GRID2 Gene Spinocerebellar Ataxia Type 18 Autosomal Recessive NGS Genetic DNA Test is a cutting-edge diagnostic tool designed to detect genetic mutations associated with Spinocerebellar Ataxia Type 18. This condition is a hereditary neurological disorder characterized by progressive loss of coordination and balance due to degeneration of the cerebellum. Understanding one’s genetic predisposition is crucial for early intervention and management of the disease.
What the Test Measures
This test utilizes Next Generation Sequencing (NGS) technology to analyze the GRID2 gene for potential pathogenic variants that may lead to Spinocerebellar Ataxia Type 18. By identifying these mutations, healthcare providers can offer targeted advice and management plans for patients and their families.
Who Should Consider This Test
Individuals with a family history of neurological disorders, particularly those exhibiting symptoms such as:
- Unexplained loss of coordination
- Difficulty walking or maintaining balance
- Slurred speech
- Muscle weakness
should consider this test. Additionally, those with a genetic predisposition to ataxia or related conditions may benefit significantly from early diagnosis.
Benefits of Taking the Test
- Identifies genetic mutations associated with Spinocerebellar Ataxia Type 18.
- Facilitates informed decision-making regarding family planning and management options.
- Provides clarity for individuals experiencing unexplained neurological symptoms.
- Enables access to specialized care and support services.
Understanding Your Results
Results from the GRID2 Gene Spinocerebellar Ataxia Type 18 test will be available within 3 to 4 weeks. A genetic counselor will assist in interpreting the results, providing a comprehensive understanding of the implications, potential risks, and available management strategies.
Test Pricing
| Discount Price | Regular Price |
|---|---|
| 40,000 KSh | 56,000 KSh |
Book Your Test Today
We have branches across all major cities in Kenya and offer home sample collection services for your convenience. To book the GRID2 Gene Spinocerebellar Ataxia Type 18 Autosomal Recessive NGS Genetic DNA Test, please call or WhatsApp us at +254746849631. Take the first step towards understanding your health today!
